US 9539234
Treatment of circadian rhythm disorders
granted A61KA61K31/00A61K31/05
Quick answer
US patent 9539234 (Treatment of circadian rhythm disorders) held by VANDA PHARMACEUTICALS INC. expires Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Jan 10 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 05 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K31/00, A61K31/05, A61K31/15, A61K31/277